Richard Mailman

Professor and College of Medicine Distinguished Senior Scholar

Richard Mailman

Publication Tags

Parkinson Disease Therapeutics Cholesterol Substantia Nigra Tocopherols Dopamine Pharmaceutical Preparations Dopamine D2 Receptors Short Term Memory Levodopa Iron Parkinsonian Disorders Serum Dopamine Receptors Selegiline Prefrontal Cortex Antipsychotic Agents Dopamine Agonists Manganese Schizophrenia Dihydrexidine Pharmacology Pars Compacta Prospective Studies Hydroxymethylglutaryl Coa Reductase Inhibitors

Most Recent Papers

Nigral MRI features of asymptomatic welders

Eun Young Lee, Michael R. Flynn, Guangwei Du, Mechelle M. Lewis, Michael Goldenberg, Lan Kong, Richard B. Mailman, Young Seoub Hong, Xuemei Huang, 2021, Parkinsonism and Related Disorders on p. 37-43

D<sub>1</sub>, not D<sub>2</sub>, dopamine receptor activation dramatically improves MPTP-induced parkinsonism unresponsive to levodopa

Richard B. Mailman, Yang Yang, Xuemei Huang, 2021, European Journal of Pharmacology

D1 dopamine receptors intrinsic activity and functional selectivity affect working memory in prefrontal cortex

Yang Yang, Sang Min Lee, Fumiaki Imamura, Krishne Gowda, Shantu Amin, Richard B. Mailman, 2021, Molecular Psychiatry on p. 645-655

Parkinson's Disease-Related Motor and Nonmotor Symptoms in the Lancaster Amish

Michael D.F. Goldenberg, Xuemei Huang, Honglei Chen, Lan Kong, Teodor T. Postolache, John W. Stiller, Katherine A. Ryan, Mary Pavlovich, Toni I. Pollin, Alan R. Shuldiner, Richard B. Mailman, Braxton D. Mitchell, 2020, Neuroepidemiology on p. 392-397

The D<sub>1</sub>/D<sub>5</sub>Dopamine Partial Agonist PF-06412562 in Advanced-Stage Parkinson's Disease

Xuemei Huang, Mechelle M. Lewis, Lauren Van Scoy, Sol De Jesus, Paul J. Eslinger, Amy C. Arnold, Amanda J. Miller, Julio Fernandez-Mendoza, Bethany Snyder, William Harrington, Lan Kong, Xi Wang, Dongxiao Sun, Marielle Delnomdedieu, Sridhar Duvvuri, Susan E. Mahoney, David L. Gray, Richard Mailman, 2020, Journal of Parkinson's Disease on p. 1515-1527

Cancer and the dopamine D<sub>2</sub> receptor

Jillian S. Weissenrieder, Jeffrey D. Neighbors, Richard B. Mailman, Raymond J. Hohl, 2019, Journal of Pharmacology and Experimental Therapeutics on p. 111-126

Effect of manganese on neural endocrine hormones in serum of welders and smelters

Shi Yan Ou, Hai Lan Luo, Richard Mailman, Zhao Cong Li, Yu Wen Zhang, Mei Cai, Xiao Wei Huang, Shao Jun Li, Yue Ming Jiang, 2018, Journal of Trace Elements in Medicine and Biology on p. 1-7

Susceptibility MRI captures nigral pathology in patients with parkinsonian syndromes

Mechelle Lewis, Guangwei Du, Jennifer Baccon, Amanda Snyder, Ben Murie, Felicia Cooper, Christy Stetter, Lan Kong, Christopher Sica, Richard Mailman, James Connor, Xuemei Huang, 2018, Movement Disorders on p. 1432-1439

Distinct progression pattern of susceptibility MRI in the substantia nigra of Parkinson's patients

Guangwei Du, Mechelle Lewis, Christopher Sica, Lu He, James Connor, Lan Kong, Richard Mailman, Xuemei Huang, 2018, Movement Disorders on p. 1423-1431

Characterization of the neurochemical and behavioral effects of solriamfetol (JZP-110), a selective dopamine and norepinephrine reuptake inhibitor

Michelle G. Baladi, Michael J. Forster, Michael B. Gatch, Richard Mailman, Danielle L. Hyman, Lawrence P. Carter, Aaron Janowsky, 2018, Journal of Pharmacology and Experimental Therapeutics on p. 367-376

Most-Cited Papers

Differential involvement of striato- and cerebello-thalamo-cortical pathways in tremor- and akinetic/rigid-predominant Parkinson's disease

Mechelle Lewis, Guangwei Du, S. Sen, A. Kawaguchi, Y. Truong, S. Lee, Richard Mailman, Xuemei Huang, 2011, Neuroscience on p. 230-239

Quantitative susceptibility mapping of the midbrain in Parkinson's disease

Guangwei Du, Tian Liu, Mechelle M. Lewis, Lan Kong, Yi Wang, James Connor, Richard B. Mailman, Xuemei Huang, 2016, Movement Disorders on p. 317-324

Statins, plasma cholesterol, and risk of Parkinson's disease: A prospective study

Xuemei Huang, Alvaro Alonso, Xuguang Guo, David M. Umbach, Maya L. Lichtenstein, Christie M. Ballantyne, Richard B. Mailman, Thomas H. Mosley, Honglei Chen, 2015, Movement Disorders on p. 552-559

Novel Dopamine Therapeutics for Cognitive Deficits in Schizophrenia

Amy F.T. Arnsten, Ragy R. Girgis, David L. Gray, Richard B. Mailman, 2017, Biological Psychiatry on p. 67-77

Effects of the D<sub>1</sub> dopamine receptor agonist dihydrexidine (DAR-0100A) on working memory in schizotypal personality disorder

Daniel R. Rosell, Lauren C. Zaluda, Margaret M. McClure, M. Mercedes Perez-Rodriguez, K. Sloan Strike, Deanna M. Barch, Philip D. Harvey, Ragy R. Girgis, Erin A. Hazlett, Richard B. Mailman, Anissa Abi-Dargham, Jeffrey A. Lieberman, Larry J. Siever, 2015, Neuropsychopharmacology on p. 446-453

Dopamine receptor signaling and current and future antipsychotic drugs

Kevin N. Boyd, Richard B. Mailman, 2012, on p. 53-86

Transcriptional repression by the BRG1-SWI/SNF complex affects the pluripotency of human embryonic stem cells

Xiaoli Zhang, Bing Li, Wenguo Li, Lijuan Ma, Dongyan Zheng, Leping Li, Weijing Yang, Min Chu, Wei Chen, Richard B. Mailman, Jun Zhu, Guoping Fan, Trevor K. Archer, Yuan Wang, 2014, Stem Cell Reports on p. 460-474

Serum cholesterol and the progression of parkinson's disease

Xuemei Huang, Peggy Auinger, Shirley Eberly, David Oakes, Michael Schwarzschild, Alberto Ascherio, Richard Mailman, Honglei Chen, 2011, PLoS One

Higher iron in the red nucleus marks Parkinson's dyskinesia

Mechelle Lewis, Guangwei Du, Michal Kidacki, Nisargkumar Patel, Michele L. Shaffer, Richard Mailman, Xuemei Huang, 2013, Neurobiology of Aging on p. 1497-1503

Projection of the prevalence of Parkinson's disease in the coming decades

Alexander Rossi, Kristin Berger, Honglei Chen, Douglas Leslie, Richard Mailman, Xuemei Huang, 2018, Movement Disorders on p. 156-159